Clinical Trials Directory

Trials / Completed

CompletedNCT05464108

Validation the Artificial Intelligence System for Automatic Evaluation of the Extent of Intestinal Metaplasia

Validation the Artificial Intelligence System for Automatic Evaluation of the Extent of

Status
Completed
Phase
Study type
Observational
Enrollment
1,080 (actual)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
40 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The operative link on gastric intestinal metaplasia assessment (OLGIM) staging systems using biopsy specimens were commonly used for histological assessment of gastric cancer risk. But its clinical application is limited for at least biopsy samples. The endoscopic grading system (EGGIM) has been shown a significant correlation with the OLGIM. The investigators designed a computer-aided diagnosis program using deep neural network to automatically evaluate the extent of IM and calculate the EGGIM scores in endoscopy examination. This study is aimed at exploring the relevance of the EGGIM scores automatically evaluated by Artificial Intelligence and OLGIM scores.

Detailed description

Gastric intestinal metaplasia(GIM) is an important stage in the gastric cancer(GC). The operative link on gastric intestinal metaplasia assessment (OLGIM) staging systems using biopsy specimens were commonly used for histological assessment of gastric cancer risk. However, its need to take at least 4 biopsies is not clinically feasible. The endoscopic grading system (EGGIM) has been shown a significant correlation with the OLGIM. An EGGIM score of 5 was the best cut off value for identifying OLGIM stage III/IV patients. The investigators have designed a computer-aided diagnosis program using deep neural network to automatically evaluate the extent of IM and calculate the EGGIM scores in endoscopy examination. This study is aimed at exploring the relevance of the EGGIM scores automatically evaluated by Artificial Intelligence and OLGIM scores.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTThe diagnosis of Artificial Intelligence and endosopistsEndosopists and AI will assess the EGGIM score independently when the patients is eligible. In addition, they can not see the OLGIM score of the patients.

Timeline

Start date
2022-07-01
Primary completion
2023-12-30
Completion
2023-12-30
First posted
2022-07-19
Last updated
2024-12-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05464108. Inclusion in this directory is not an endorsement.